New England Research & Management, Inc. GlaxoSmithKline ADS Transaction History

New England Research & Management, Inc.

  • $213 Million
  • Q3 2024
Number of Shares
16,992
Previous 19,592 13.27%
Holding current value
$695,000
Previous $754,000 7.82%
% of portfolio
0.33%
Previous 0.36%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
N/A
-2,600 Reduced 13.27%
16,992 $695,000
Q2 2024

Jul 09, 2024
SELL
N/A
-1,546 Reduced 7.31%
19,592 $754,000
Q1 2024

Apr 16, 2024
SELL
N/A
-492 Reduced 2.27%
21,138 $906,000
Q3 2023

Oct 10, 2023
SELL
N/A
-640 Reduced 2.87%
21,630 $784,000
Q2 2023

Jul 05, 2023
BUY
N/A
995 Added 4.68%
22,270 $794,000
Q1 2023

Apr 06, 2023
BUY
N/A
75 Added 0.35%
21,275 $757,000
Q4 2022

Jan 09, 2023
SELL
N/A
-4,840 Reduced 18.59%
21,200 $745,000
Q3 2022

Oct 06, 2022
BUY
N/A
26,040 New
26,040 $766,000
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email